SPS
CLB icon

Susquehanna Portfolio Strategies’s Core Laboratories CLB Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-17,425
Closed -$308K – 813
2023
Q4 		$308K Buy
+17,425
New +$351K 0.01% 856

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Susquehanna Portfolio Strategies's CLB Position: Q1 2024 in Review

Susquehanna Portfolio Strategies sold out of Core Laboratories (CLB) in Q1 2024, closing a stake of 17,425 shares — an estimated $308K sold.

Susquehanna Portfolio Strategies first reported a position in CLB in Q4 2023 and held it in 1 quarter. The position peaked at $308K in Q4 2023. 197 funds tracked by Wall St. Rank hold CLB as of Q1 2024.

  • Susquehanna Portfolio Strategies reported no remaining Core Laboratories position as of Q1 2024 after selling out during the quarter.
  • Susquehanna Portfolio Strategies sold 17,425 Core Laboratories shares in Q1 2024, an estimated $308K.
  • Susquehanna Portfolio Strategies first reported a position in Core Laboratories in Q4 2023 and held it in 1 quarter.
  • Susquehanna Portfolio Strategies's Core Laboratories position peaked at $308K in Q4 2023.
  • 197 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2024.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2024, filed 7 May 2024.